Shop CVS Pharmacy for a Cause

Tobacco-Free Generation Campus Initiative

Last fall, the Society launched a bold new initiative, the Tobacco-Free Generation Campus Initiative (TFGCI), which will provide grants to accelerate and expand the adoption and implementation of 100% smoke-free and tobacco-free policies on college and university campuses across the nation. The TFGCI initiative, under the direction of the American Cancer Society's Center for Tobacco Control, is supported by the CVS Health Foundation as part of “Be The First,” CVS Health's five-year, $50 million initiative that supports education, advocacy, tobacco control, and healthy behavior programming to help deliver the nation's first tobacco-free generation.

The TFGCI kicked off last fall, awarding grants to 20 colleges and universities that began in October 2016. The second round of grants was awarded to 42 schools and will begin in August 2017. Over the course of three years, the $3.6 million multi-year program will award grants to 125 colleges and universities throughout the U.S. with the greatest need for stronger tobacco prevention and control.

The grants will help schools successfully advocate for, adopt, and implement 100 percent smoke-free and tobacco-free campus policies. Campuses will also receive technical assistance and resources to support their efforts with education, communications, cessation, and evaluation.

A few more rounds of TFGCI grant applications are anticipated before 2019, which will be announced on the Tobacco Free Generation Initiative page.

Of the roughly 20 million college and university students in the U.S., more than one million are projected to die prematurely from cigarette smoking. While approximately 90% of smokers start by age 18, fully 99 % start by age 26, underscoring the importance of supporting those in the young adult age group with more effective prevention and cessation efforts while eliminating exposure to secondhand smoke and all tobacco use in their learning environments.

Focus on the global cancer burden

CVS Health President and CEO, Larry Merlo, and Johnson & Johnson Chairman and CEO, Alex Gorsky, are founding members of the American Cancer Society’s CEOs Against Cancer® Global Council. They join CEOs from Delta, Motorola Solutions, IBM, and other multinational corporations who are united in leading the fight for a world without cancer.

Established in 2017, the CEOs Global Council represents a diversity of thought leadership and expertise, serving in an advisory capacity as partners to help drive mission outcomes, support a culture of health, and sustain impact on reducing the global cancer burden. These executive leaders provide a critical global perspective on how cancer affects business and commerce, employees and their families, and communities around the world.  Their insights help drive the Society’s mission to change the course of cancer today and in the future. Learn more about the Society’s CEOs Against Cancer® Global Council.

Additional involvement

Janssen Pharmaceuticals, owned by Johnson & Johnson, also supports the Society’s Relay For Life and Making Strides Against Breast Cancer program, as well as the Coaches vs. Cancer program in Philadelphia and the Society’s sister advocacy organization, the American Cancer Society Cancer Action Network.

Share this article: